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Abstract
The NF-kB pathway is involved in immune and inflammation responses, proliferation, differentiation and cell death or
survival. It is activated by many external stimuli including genotoxic stress. DNA double-strand breaks activate NF-kBi na n
ATM-dependent manner. In this manuscript, a direct interaction between p65(RelA) and the N-terminal extremity of ATM is
reported. We also report that only one of the five potential ATM-(S/T)Q target sites present in p65, namely Ser
547,i s
specifically phosphorylated by ATM in vitro. A comparative transcriptomic analysis performed in HEK-293 cells expressing
either wild-type HA-p65 or a non-phosphorylatable mutant HA-p65S547A identified several differentially transcribed genes
after an etoposide treatment (e.g. IL8, A20, SELE). The transcription of these genes is increased in cells expressing the
mutant. Substitution of Ser
547 to alanine does not affect p65 binding abilities on the kB site of the IL8 promoter but reduces
p65 interaction with HDAC1. Cells expressing p65S547A have a higher level of histone H3 acetylated on Lys
9 at the IL8
promoter, which is in agreement with the higher gene induction observed. These results indicate that ATM regulates a sub-
set of NF-kB dependent genes after a genotoxic stress by direct phosphorylation of p65.
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Introduction
Genomic integrity is continuously challenged by endogenous
and external threats such as genotoxic chemicals or ionizing
radiation (IR). DNA damage, and in particular DNA double-
strand breaks (DSB), generated by these agents, are extremely
deleterious. Indeed they can lead to genetic variation, aging, cell
death or carcinogenesis. Cells activate a complex signaling
network, called the DNA Damage Response (DDR), to respond
to those injuries and avoid such consequences [1,2]. Sensor
proteins detect DNA lesions and transmit the signal to transducer
proteins which, in turn, convey the signal to numerous
downstream effectors involved in specific pathways. Upon DSB
formation, the main transducer protein of the DDR is Ataxia
telangiectasia mutated (ATM), a large mostly nuclear kinase.
Indeed, upon detection of DSB, ATM is rapidly activated and can
next phosphorylate a vast amount of substrates implicated in DSB
repair, check-point activation, apoptosis and transcription factors
regulation, including p53 and the nuclear factor kappa B (NF-kB)
[3,4,5].
NF-kB is an important regulator of diverse cellular processes,
including immune response, inflammation, cell survival, pro-
liferation, differentiation, adhesion and apoptosis [6,7]. Aberrant
activation of NF-kB pathway has been implicated in many
pathogenesis. In particular, NF-kB constitutive activation con-
tributes to the growth and malignancy of cancer cells and also
affects the tumor response to many types of chemotherapy and
ionizing radiation. It often favors survival and thereof the
apparition of detrimental resistance phenomenon [8,9].
NF-kB family includes five members, p65(RelA), RelB, c-Rel,
p105/p50 and p100/p52, which assemble in homodimers or
heterodimers to form active transcription factors that regulate
a wide array of target genes. The NF-kB p50–p65 complex
represents the most abundant member of the NF-kB family [10].
In this dimer, p65(RelA) possesses a transactivating function while
p50 does not. In resting cells, NF-kB complexes are bound to
inhibitor of NF-kB( I kB) proteins such as IkBa, and remain
inactive in the cytoplasm. Distinct signaling cascades, induced by
various stimuli such as tumor necrosis factor a (TNFa), lipopoly-
saccharide (LPS) or genotoxic agents, activate NF-kB pathway via
the IkB kinase (IKK) complex activation. This complex is
composed of two catalytic subunits (IKKa and IKKb) and one
regulatory subunit named IKKc or NEMO for NF-kB essential
modulator [11]. In response to DSB, ATM kinase is required for
IKK activation at two levels. On the one hand, ATM
phosphorylates NEMO in the nucleus [12]. This phosphorylation
PLoS ONE | www.plosone.org 1 June 2012 | Volume 7 | Issue 6 | e38246Figure 1. p65 interaction with ATM and p65 Ser
547 phosphorylation by ATM. (A) Confirmation of a direct interaction between ATM and
p65. Bacterially expressed GST or GST-ATM (1–247) fusion protein were purified on glutathione agarose beads and used to pull-down p65 from HEK-
293 over-expressing HA-p65 cell lysate. Pulled down p65 was detected by immunoblotting with a p65 antibody (upper panel) and GST proteins were
stained with coomassie bleu on the PVDF membrane. (B) Identification of the ATM target residue. Schematic representation of the different GST-p65
substrates used in the kinase assay. (C) In vitro kinase assay. Immunoprecipitated ATM from HEK-293 cells was incubated with GST-p53 and different
GST-p65 proteins in presence of [c2
32P]ATP. The radiolabelled bands (upper panels) represent auto-phosphorylated ATM, phosphorylated GST-p53
or GST-p65. Levels of ATM and of substrate present in each reaction were determined by western blotting and by coomassie blue staining
respectively (lower panels). (D) As in (C) In vitro kinase assay but with wt or mutated GST-p53 and GST-p65 proteins as substrates. ATM inhibitor
KU55933 was added in some reaction samples as indicated. The same detection methodology than in (C) was used. (E) As in (D) in vitro kinase assay,
but with purified recombinant ATM wt or kd instead of immunoprecipitated ATM and KU55933 utilization. (F) Conservation of Ser
547 among different
species. Alignment of p65 C-terminal sequence from different mammalian and bird species.
doi:10.1371/journal.pone.0038246.g001
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leads to subsequent NEMO mono-ubiquitination and nuclear
export. These sequential modifications of NEMO are essential for
IKK complex activation [13]. On the other hand, following DSB,
ATM is partially exported to the cytoplasm where it allows TGF-
beta activated kinase 1 (TAK1) activation and TNF receptor-
associated factor 6 (TRAF6) poly-ubiquitination, two additional
steps also required for full IKK complex activation [14,15]. Once
activated, the IKK complex phosphorylates IkBa, leading to its
recognition by the SCF
bTrCP and resulting in its poly-ubiquitina-
tion and subsequent degradation by the 26S proteasome. NF-kB
released from IkBa inhibitor translocates to the nucleus, binds to
DNA and regulates genes expression [11].
NF-kB activity is controlled by highly regulated mechanisms.
Indeed, post-translational modifications of NF-kB subunits also
modulate gene transcription. p65 is phosphorylated on different
residues (e.g. Ser
276, Ser
311, Ser
468, Thr
505, Ser
529, Ser
536)b y
multiple kinases (e.g. PKAc, MSK1, GSK3b, Chk1, CKII, RSK1,
IKKe, IKKa, IKKb) in response to diverse stimuli, and these
phosphorylations were shown to have an effect on NF-kB activity
[16,17]. Indeed they can affect (i) NF-kB nuclear translocation, (ii)
DNA binding or (iii) gene transcription. p65 phosphorylations can
modulate positively as well as negatively gene induction, by
increasing or decreasing co-activator and co-repressor recruit-
ment. Moreover, p65 can be reversibly acetylated by histone
acetyltransferase (HAT) (e.g. CBP/p300, PCAF) on multiple
residues (Lys
122, Lys
123, Lys
218, Lys
221, Lys
310, Lys
314 and Lys
315).
p65 acetylations also play different roles in NF-kB activation
[16,17]. Through the study of p65 post-translational modifica-
tions, the molecular mechanisms underlying the regulation of
specific target genes are better understood and reveal a growing
complexity.
This study shows that ATM kinase directly phosphorylates p65
on Ser
547 in response to DSB. This interaction between ATM and
p65 highlights a third level of NF-kB regulation by ATM kinase.
In addition, it also demonstrates that this phosphorylation
decreases the expression of a specific set of NF-kB target genes
implicated in inflammation, by a mechanism involving histone
deacetylase (HDAC) recruitment.
Results
Interaction between ATM and p65 and Phosphorylation
of p65 by ATM
ATM is the main mediator of the DSB-induced DDR, therefore
the identification of new binding proteins would help in the
understanding of the signaling pathways induced by DNA breaks.
In order to discover new interacting proteins, a yeast two-hybrid
screen was performed. ATM (1–150) (HEAT repeats 1–2) was
used as bait and a HeLa cDNA library as prey. The N-terminal
part of ATM was chosen because it is known to interact with other
proteins and substrates [18]. Twelve different proteins, including
ATM itself and p65, were identified as potential ATM-binding
proteins. In an X-Gal filter test, an intense blue coloration rapidly
developed in the colony expressing p65 while this coloration was
weaker and slower to develop in the colony expressing ATM.
These results suggested a strong interaction between ATM and
p65. The presence of ATM, known to form homodimer, among
the prey validated the screen. Given the important roles of ATM
kinase in DSB-induced NF-kB pathway, p65(RelA) seemed to be
of great interest for further studies.
In a first time the interaction between ATM N-terminal
extremity and p65 was investigated by GST pull-down assay,
using purified GST-ATM(1–247) fusion protein. Cellular extracts
from cells over-expressing HA-p65 were mixed with GST-ATM or
with GST alone as negative control. These results showed an
interaction between p65 and GST-ATM(1–247), but not between
p65 and GST, confirming the existence of a stable interaction
between p65 and ATM (Fig. 1A).
ATM is a kinase with multiple substrates [19]. In order to
investigate whether p65 could be one of them, an in silico analysis
of p65 primary structure was performed. This analysis revealed
five (S/T)Q motives (Ser
131, Ser
240, Ser
374, Thr
429, Ser
547). This
motif is the minimal established consensus sequence targeted by
ATM kinase [20]. The phosphorylation of these residues was
investigated by an in vitro kinase assay using different purified
GST-p65 fusion proteins as substrates. The different GST-p65
fusion proteins contain between 30 to 50 amino acids of p65
surrounding each candidate phosphorylation site (Fig. 1B). These
GST-p65 proteins were incubated with immunoprecipitated active
ATM and [c2
32P]ATP. A phosphorylation of the substrates
containing the Ser
240 and the Ser
547 was observed (Fig. 1C). Two
additional assays were conducted to confirm the specificity of the
detected radioactive signal. The kinase assay was repeated (i) with
mutated GST-p65 fusions proteins, in which the putative targeted
serine was replaced by an alanine, or (ii) in presence of a specific
ATM kinase inhibitor (KU55933). These experiments showed
a specific phosphorylation of Ser
547 by ATM kinase but not of
Ser
240. Indeed, the phosphorylation of the substrate disappeared
when mutated GST-p65(531–551) was used or when the inhibitor
KU55933 was added in the reaction sample (Fig. 1D left panel),
whereas, for the substrate containing the Ser
240, it did not (Fig. 1D
right panel). Ser
15 of p53 being a well known target of ATM [21],
GST-p53(9–22) wt or mutated were taken as controls. The lack of
ATM auto-phosphorylation in presence of the inhibitor further
validates this test (Fig. 1D top panels). Moreover, to confirm the
phosphorylation of the Ser
547 of p65 by ATM kinase by an
independent assay, an experiment was performed using purified
recombinant ATM wt or kd instead of the immunoprecipitated
kinase. This additional kinase assay also showed a specific
phosphorylation of the Ser
547 of p65, confirming completely the
specificity of the signal observed to ATM kinase (Fig. 1E). From
these experiments, we can conclude that the p65 subunit of NF-kB
interacts with ATM to be phosphorylated on its Ser
547. This
residue is located in the transactivation domain 1 (TAD1) of p65 at
the C-terminal extremity. It is evolutionary conserved and found
in mammalian and in bird species too (Fig. 1E) [22].
Role of p65 Ser
547 Phosphorylation on Global
Transcriptional Activity
To investigate the effects of p65 Ser
547phosphorylation on
transcriptional NF-kB activity, a phospho-null (S547A) mutation
of this site was generated. HEK-293 cells, transfected either with
p65wt or p65S547A expression plasmids and luciferase reporter
plasmids, were treated with etoposide to induce the DDR cascade.
The results indicate an expected increased luciferase activity of the
non-transfected cells treated with etoposide, but they did not
reveal any difference in luciferase activity between cells over-
expressing wt or S547A mutated p65 (Fig. 2A). Over-expressed
p65 wt or mutated are both able to induce NF-kB activity
independently of etoposide treatment. Nevertheless, these results
indicate (i) that the mutant does not exercise a dominant negative
effect and (ii) that the phosphorylation of this residue does not have
a global impact on the transcriptional potential of p65. However
Ser
547 phosphorylation could have a gene specific effect. Indeed,
several other p65 post-translational modifications are known to
have gene specific effects [16,23,24].
p65 Ser
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p65S547A
To study the physiological role of Ser
547 phosphorylation,
a cellular model which activates NF-kB in response to DSB and
which expresses either wt or S547A mutated p65 was created.
HEK-293 cells were used and a strategy was adopted to down-
regulate endogenous p65 and to re-introduce a HA-tagged wt or
S547A p65 plasmid at an expression level similar to the
endogenous one. Therefore, two silent mutations were inserted
in the p65 sequence targeted by a p65 siRNA (Fig. 3A). HEK-293
cells were stably transduced by lentiviral infection with this siRNA
resistant HA-p65, and endogenous p65 was next down-regulated
with siRNA. Western blot experiments showed that endogenous
p65 was down-regulated by the p65 siRNA whereas the wt and
S547A HA-p65 were not (Fig. 3B). An inducible translocation of
HA-p65 was also observed in response to etoposide, demonstrating
the functionality of the exogenous p65. To further check the
functionality of this cellular model, EMSA (Fig. 3C) and qRT
PCR (Fig. 3D) were performed. By EMSA, NF-kB binding in
response to DNA damage was observed, as expected (Fig. 3C top
panel). The residual binding observed in HEK-293 cells depleted
in endogenous p65 corresponds to p50/p50 binding, as shown by
the supershift experiment (Fig. 3C bottom panel). Quantitative
analysis of IkBa mRNA level showed the inducible expression of
NF-kB target genes in response to etoposide in the model,
demonstrating once again its functionality (Fig. 3D). Moreover, the
qRT PCR experiment showed that, even if endogenous p65 was
not completely knocked out by the siRNA, the residual amount of
endogenous p65 protein is no longer sufficient to induce gene
expression. In regard of these data, we obtained a functional
cellular model, expressing exclusively wt or S547A mutated p65,
which activates NF-kB in response to DSB.
Regulation of a Set of Specific NF-kB Target Genes by
p65 Ser
547 Phosphorylation
A transcriptomic analysis by microarray Illumina was per-
formed, in this cellular model after 4 and 8 hours of etoposide
treatment, in order to identify the genes specifically regulated by
the Ser
547 phosphorylation of p65 in response to DSB. The
microarray revealed a group of around fifteen genes differentially
regulated between cells expressing wt and S547A mutated p65
(Tab 1). The expression level of these genes was always higher in
cells expressing S547A mutated p65 compared to wt p65,
indicating a possible repressor role for the phosphorylation of
the Ser
547. Most of these genes were already described as NF-kB-
dependent genes and often implicated in inflammation. The
different mRNA expression level between both cell types was
confirmed by qRT PCR for some of the genes (Fig. 4A–F). The
results of the microarray were further validated at the protein
expression level by ELISA for interleukin 8 (IL8) chosen as model
for further investigations (Fig. 5A). To prove that the higher gene
induction observed in cells expressing p65S547A is effectively due to
the lack of phosphorylation of this residue, a HEK-293 cell line
expressing exclusively a phospho-mimicking (S547D) mutant of
p65 was obtained. Etoposide-induced IL8 and IkBa gene
expression was next analyzed in these cells by qRT PCR (Fig. 6A
and 6B). Interestingly, no difference of IL8 gene induction was
observed between cells expressing the wt and the S547D mutant
form of p65, whereas the higher gene expression was again
observed in cells expressing p65S547A. As expected, IkBa, which
was not among the set of genes regulated by the phosphorylation
of the Ser
547 of p65, showed an identical induction in the three
different cell lines. In conclusion, p65 phosphorylation on Ser
547 in
response to DSB leads to a decreased induced expression of
a specific set of genes mainly involved in inflammation.
Mechanism of Gene Expression Down-regulation by p65
Ser
547 Phosphorylation
Next, we investigated how p65 Ser
547 phosphorylation could
affect the transcription of this set of genes. To perform this study
we focused on IL8 gene. The etoposide-induced binding of wt and
S547A mutated p65 to IL8 promoter were compared by EMSA
(Fig. 7A), and by p65 ChIP assay (Fig. 7C). No difference was
observed, ruling out the hypothesis of a lower gene induction being
the result of a lower recruitment of phosphorylated p65 onto the
promoter. For the EMSA experiment, a supershift by a p65
antibody was performed. It showed that the signal observed was
due to a p65 containing complex, likely p50/p65 (Fig. 7B).
A second possible explanation for the lower gene expression in
cells containing wt p65 could be the recruitment of a co-repressor.
HDAC are well-characterized gene expression repressors, known
to be differentially recruited following specific p65 post-trans-
lational modifications. For this reason, HDAC recruitment
following p65 phosphorylation was investigated. First, we observed
the effect of trichostatin A (TSA) treatment, an HDAC inhibitor,
on IL8 expression after etoposide treatment, in cells expressing wt
or S547A mutated p65. Interestingly, TSA treatment increased
etoposide-induced IL8 expression in cells containing wt p65
whereas it did not affect IL8 expression in cells containing S547A
mutated p65 (Fig. 8A). This meant that HDAC probably affect
IL8 expression only when p65 is phosphorylated. To confirm the
specificity of the sensitivity to TSA for phosphorylated p65, we
performed the same experiment with IkBa, a gene not regulated
by p65 Ser
547 phosphorylation. Surprisingly, it was observed that
TSA also affected IkBa gene expression. However, the lower IkBa
gene expression was observed both in cells containing p65wt as well
Figure 2. No impact of p65 Ser
547 phosphorylation on global
NF-kB transcriptional activity. (A) HEK-293 cells were transfected
with kB Luciferase plasmid and with increasing amount of either wt or
S547A mutated p65. Twenty-four hours later the cells were treated for
8 h with etoposide or left untreated. NT, non transfected.
doi:10.1371/journal.pone.0038246.g002
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following etoposide treatment was sensitive to TSA but, in the
contrary of IL8 gene, in a p65 Ser
547 phosphorylation-indepen-
dent manner.
To confirm HDAC recruitment following p65 phosphorylation,
we looked for the presence of acetylated histone on IL8 promoter
in cells expressing wt and S547A mutated p65 by ChIP assay.
ChIP experiment showed an increasing amount of acetylated
histone 3 (Lys9) onto IL8 promoter following etoposide treatment
in cells containing S547A mutated p65, and a decreasing amount
of acetylated histone 3 in cells expressing wt p65 in the same
conditions (Fig. 8C). The same experiment was performed with
IkBa promoter on which no difference of histone 3 acetylation
between cells expressing wt and mutated p65 was observed
(Fig. 8D). This test showed almost no change of histone H3
acetylation following etoposide treatment on IkBa promoter. All
of these results showed evidence for HDAC recruitment by
phosphorylated p65 onto promoters of the genes specifically
regulated by Ser
547 phosphorylation. Next, co-immunoprecipita-
tions between wt p65 or mutated p65 and HDAC were performed
to compare potential differences in HDAC interaction. It can be
seen on Fig. 8E that wt p65, but not mutated p65, interacts with
HDAC1 after 5 hours of etoposide treatment. To further confirm
the recruitment of HDAC1 on IL8 promoter by phosphorylated
p65, HDAC1 ChIP assay was performed. This experiment showed
a higher recruitment of HDAC1 after 5 hours of etoposide
treatment in cells expressing wt p65 compared to cells expressing
S547A mutated p65, corroborating the result of the co-immuno-
precipitation (Fig. 8F). These data indicate that the phosphoryla-
Figure 3. Creation of HEK-293 cell lines expressing either wt or S547A mutated p65. (A) Schematic representation of the 2 silent
mutations inserted in the sequence of p65 within the sequence targeted by p65 siRNA, conferring to exogenous HA-p65 the resistance to the siRNA.
(B) Western blot analysis of cytoplasmic and nuclear p65 protein (p65 antibody) and of exogenous p65 (HA antibody) in non-treated or etoposide
treated HEK-293 and HEK-293 stably expressing sip65 resistant HA-p65. All cell lines were either transfected with control or p65 siRNA. (C–D)
Comparison of NF-kB activation after etoposide treatment, by (C) EMSA and by (D) qRT PCR of IkBa mRNA, between HEK-293 and HEK-293 stably
expressing sip65 resistant HA-p65. All cell lines were transfected either with control or p65 siRNA. (C) NF-kB DNA binding was analyzed using a probe
corresponding to the HIV-1 long terminal repeat kB site (top panel). The presence of p65 and p50 protein in the binding complex observed in HEK-
293 was analyzed by supershift with p65 and p50 antibodies (bottom panel). ns, non specific band.
doi:10.1371/journal.pone.0038246.g003
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interaction with HDAC1.
Table 1. Genes regulated by p65 Ser
547 phosphorylation.
p65 wt p65 S547A
Gene Symbol Etop 4 h (FI) Etop 8 h (FI) Etop 4 h (FI) Etop 8 h (FI)
SELE 2,30 4,82 5,51 18,73
A20 5,89 7,07 11,66 14,47
IL8 3,19 5,31 6,22 11,51
PI3 2,43 4,57 4,65 9,60
CXCL2 1,49 1,17 2,77 1,97
CXCL1 3,38 2,47 6,02 4,05
CD83 3,25 3,94 5,19 6,45
CCL20 11,55 39,21 18,37 52,53
GADD45B 2,68 2,12 4,18 2,33
TNF 4,27 5,47 6,20 7,03
VCAM1 1,06 1,84 1,42 3,83
BIRC3 1,38 2,33 1,83 3,47
C1QTNF1 1,25 1,57 1,36 2,50
SGPP2 1,04 2,81 1,12 4,38
List of genes differentially expressed in HEK293 cells expressing exclusively wt
or S547A mutated p65, and their fold induction (FI) after treatment with
etoposide. Gene symbol in the first column, fold induction after etoposide
treatment for the indicated periods (compared to non-treated cells) and in the
indicated cell line, in the following columns. Data obtained from the microarray
experiment analysis.
doi:10.1371/journal.pone.0038246.t001
Figure 4. Higher expression of specific genes in cells expressing S547A mutated p65. qRT PCR analysis of IL8 (A), A20 (B), Sele (C), VCAM1
(D), CXCL1 (E) and CD83 (F) mRNA level after 4 and 8 hours of etoposide treatment in HEK-293 cells expressing either p65wt or p65S547A.
doi:10.1371/journal.pone.0038246.g004
Figure 5. Higher IL8 protein level in cells expressing S547A
mutated p65. ELISA analysis of IL8 protein level after the indicated
times of etoposide treatment in HEK-293 cells expressing either p65wt
or p65S547A.
doi:10.1371/journal.pone.0038246.g005
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promoters and in particular on IL8 promoter, phosphorylation
of p65 by DSB-activated ATM leads to interaction with HDAC1
which deacetylates histones, leading to a decreased gene
transcription.
Discussion
The primordial role of ATM kinase in NF-kB activation by
DSB was demonstrated some years ago [25,26], but the different
molecular mechanisms by which it controls this signaling cascade
are continuously uncovered. In 2006, ATM was shown to
phosphorylate NEMO in the nucleus [12]. More recently, it was
demonstrated that ATM is also required in the cytoplasm for
TAK1 activation and TRAF6 poly-ubiquitination [14,15]. Our
data show a third level of NF-kB regulation by ATM via the direct
interaction with the NF-kB subunit p65 and its phosphorylation
on the Ser
547. The exact domain of p65 interacting with ATM was
not investigated. Nevertheless, a direct interaction between the
TAD1 domain of p65 and ATR or DNA-PK, two kinases
belonging to the phosphoinositide-3-kinase like kinase (PIKK)
family like ATM, has been reported [27]. As the targeted serine is
localized in this domain, ATM probably also interacts with the
TA1 domain of p65.
The kinase assays showed an incorporation of radioactivity in
the GST-p65(521–551) containing the Ser
547, but also in the
Figure 6. Similar etoposide-induced gene expression profile in cells expressing wt and S547D mutated p65. qRT PCR analysis of IL8 (A),
and IkBa (B) mRNA level after 4 and 8 hours of etoposide treatment in HEK-293 cells expressing either p65wt, p65S547A, or p65S547D.
doi:10.1371/journal.pone.0038246.g006
Figure 7. Identical binding of wt and S547A mutated p65 to IL8 kB site. (A) NF-kB binding to IL8 promoter, in HEK-293 cells expressing
either p65wt or p65S547A, non-treated or treated with etoposide, was analyzed by EMSA with a probe corresponding to the kB site of IL8 promoter. (B)
The presence of p65 protein in the binding complex observed in (A) was analyzed by supershift with p65 antibody. (C) Recruitment of p65 on IL8
promoter was measured by p65 ChIP assay in HEK-293 cells expressing either p65wt or p65S547A, and treated with etoposide for the indicated periods.
ns, non significantly different.
doi:10.1371/journal.pone.0038246.g007
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still observed in presence of the ATM inhibitor and when the
putative targeted serine (Ser
240) is mutated. It indicates the
presence of another kinase in the immunoprecipitate.
By phosphorylating p65, ATM acts downstream of IKK
activation. Indeed, the Ser
547 phosphorylation does not affect
IkBa phosphorylation or p65 translocation (data not shown).
Nevertheless the exact cellular compartment where Ser
547
phosphorylation takes place is still unknown. Because this
phosphorylation does not affect p65 translocation, we can
hypothesize that it occurs in the nucleus. As Ser
547 phosphory-
lation affects the transcription of only few specific genes, we can
even assume that ATM could be recruited onto these specific
promoters where it could phosphorylate p65. Further experiments
are needed to explore this possibility.
For the study of the physiological impact of Ser
547 phosphor-
ylation following DNA damage, we could not use rescued MEF
p652/2 with p65wt or p65S547A, which would have been a quite
simple model to use. Strikingly, p65 rescued MEFs, as well as
independent MEFs p65+/+, do not activate NF-kB in response to
Figure 8. Ser
547 phosphorylation–dependent IL8 gene regulation mechanism involve HDAC. (A–B) HEK-293 expressing either p65wt or
p65S547A were non-treated or treated 4 hours with etoposide in absence or presence of TSA, and mRNA levels of IL8 (A) and IkBa (B) were analyzed
by qRT PCR. (C–D) Recruitments of Lys
9 acetylated histone 3 on IL8 (C) and IkBa (D) promoters were measured by ChIP assay in HEK-293 cells
expressing either p65wt or p65S547A, and treated with etoposide for the indicated periods. (E) HA-tagged p65wt or p65S547A were immunoprecipitated
from lysates of HEK-293 cell transfected with expression plasmid for these two proteins or non transfected as control. Co-immunoprecipitated HDAC1
protein was detected by western blotting (upper panel). Level of immunoprecipitated HA-p65 in the different samples was determined by western
blotting (lower panel). A portion of whole cell extract was added on the gel as input. (F) Recruitment of HDAC1 on IL8 promoter was measured by
ChIP assay in HEK-293 cells expressing either p65wt or p65S547A, and treated 5 hours with etoposide or left untreated. *, significantly different
(P,0.05); ns, non significantly different.
doi:10.1371/journal.pone.0038246.g008
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these cells (data not shown and discussed in [28]). That is why we
choose HEK-293 cells in which NF-kB activation is observed in
response to DNA damage. Nevertheless, over-expression of p65
induces NF-kB activation to a level too high to observe any further
gene regulation following genotoxic stress (Fig. 2A and data not
shown). Therefore, HEK-293 cells were transduced with a low
amount of wt or S547A mutant p65 and endogenous p65 was
down-regulated by siRNA. This adopted strategy provided an
adequate cellular model for the study of p65 phosphorylation
following genotoxic stress.
Phosphorylation of NEMO by ATM, and ATM-dependent
TAK1 activation or TRAF6 polyubiquitination, are steps abso-
lutely required for DSB-induced NF-kB activation [14,15]. By
contrast, Ser
547 phosphorylation of p65 by ATM is a mechanism
enabling a finely tuned NF-kB regulation. Indeed, this phosphor-
ylation does not affect global NF-kB transcriptional potential, but
regulates the expression of a set of specific genes. It is now largely
accepted that the physiological role of NF-kB activation is quite
complex and depends on the nature of the stimulus or on the cell
type [17,29]. Post-translational modifications, such as Ser
547
phosphorylation, which are highly promoter-specific, could
explain the specificity and selectivity required to produce this
context-dependent NF-kB response. The microarray experiment
identified a set of genes regulated by Ser
547 phosphorylation
mainly implicated in inflammation. Given the controversial but
critical role of inflammation in tumor growth [30,31], it would be
interesting to analyze the physiological implications of Ser
547
phosphorylation, on inflammation induction, following DNA
damage.
Post-translational modifications of p65 can modulate NF-kB
activity by different ways, and these mechanisms are context-
dependent. For example, the phosphorylation of Ser
536 by RSK1
was shown to facilitate NF-kB nuclear import by decreasing p65
affinity for IkBa [32], whereas the phosphorylation of the same
residue by IKKa in response to LPS is required for the removal of
p65 from NF-kB-dependent promoter [33]. p65 phosphorylations
modulate also co-activator or co-repressor recruitment. Indeed,
phosphorylation of Ser
276 of p65 facilitates CBP/p300 recruitment
to the promoters of NF-kB target genes [34]. On the opposite,
Thr
505 phosphorylation leads to HDAC recruitment and sub-
sequent gene repression [23], whereas phosphorylation of Thr
435
decreases p65 interaction with HDAC1, enhancing gene expres-
sion [24].
Here we observe that Ser
547 phosphorylation does not affect
p65 DNA binding (Fig. 7A and 7C) but has an important impact
on gene transcription. Indeed we observe around two fold higher
gene induction in cells expressing S547A mutated p65 compared
to cells expressing wt p65. When we look at the basal gene
expression level, an increased gene expression in cells containing
S547A mutant p65 is also sometimes observed. This observation is
not systematic and is probably due to a low basal level of stress in
the cells. ATM is not only activated by DNA damage. Other
stimuli such as hypotonic shock, oxidative stress and even TNFa
treatment were shown to activate ATM [35,36,37]. It would be
interesting to investigate whether ATM would also phosphorylate
p65 following these stimuli and the subsequent impact of such
a phosphorylation on gene transcription, compared to the present
results with DNA damage. These investigations would also help in
the understanding of the specificity of NF-kB response following
different stimuli.
Comparison of sensitivity to TSA or promoter acetylation, of
IL8 and IkBa, clearly show that the regulation mechanisms of
these two genes are completely different (Fig. 8A–D). As expected
given the results obtained from the microarray, IL8 expression
regulation depends on Ser
547 phosphorylation whereas for IkBa it
does not. In addition to this regulation gene mechanism, IL8 and
IkBa genes expression does not respond to TSA treatment in the
same way in cells containing p65wt. Indeed, whereas TSA
treatment has a no effect on IL8 expression, this treatment
induces a significant decrease of IkBa mRNA level. This reveals
an additional regulation mechanism for IkBa gene expression in
response to etoposide. When we kook at the different studies on
HDAC inhibitors, TSA could act at different levels to induce this
decreased IkBa gene expression [38,39,40]. These observations
indicate that probably several molecular regulation mechanisms
coexist for the regulation of different NF-kB target genes, even in
the same cell type and in response to the same stimulus.
In this study we highlight that Ser
547 phosphorylation of p65
following etoposide enables interaction with HDAC1 which leads
to histone deacetylation on gene promoter and subsequent
decreased gene expression, but this phosphorylation could also
play some other additional functions. It could displace a co-
activator, such as HAT, recruitment or could be important for
induction of other p65 post-translational modifications, such as
acetylations. Indeed, some cases of crosstalk between phosphor-
ylation and acetylation of p65 have been already described
[16,41]. p65 acetylations can either enhance or reduce NF-kB
activity. Of note that, as phosphorylation, acetylation can
modulate expression of only few specific target genes [16].
Ser547 phosphorylation of p65 could also interfere with p53
association. Indeed, it exist considerable crosstalk between these
two transcription factors which can cooperate with each other for
gene transcription under some circumstances [42,43,44]. The
possible modulation of DNA damage-induced interaction between
NF-kB and p53 by Ser
547 phosphorylation of p65 on specific
promoters could highlight an additional regulatory mechanism of
gene expression. All of these last hypotheses would need further
investigations to be elucidated.
Taking these results together, with the discovery of Ser
547
phosphorylation of p65, we highlight a new, finer and specific,
regulatory role of ATM in NF-kB regulation. It is now clear that
p65 phosphorylations are important to determine its transcrip-
tional functions on specific target genes through the modulation of
interaction with co-activator or co-repressor. In this study,
a decreased expression of a specific set of genes involved in
inflammation due to recruitment of HDAC by phosphorylated
p65 was observed. This is an additional regulatory mechanism
controlling NF-kB response to DSB. Concerning clinical therapy
based on the control of NF-kB activity, if we consider the possible
use of drugs that selectively regulate NF-kB activity by affecting its
post-translational modification instead of global NF-kB inhibitors,
which have probably stronger side effects, this discovery would
help in the development of such therapies.
Materials and Methods
Cell Lines and Culture and Reagents
Human embryonic kidney-293 cell line (HEK-293) (ATCC) and
HEK-293FT (Invitrogen), were cultured in Dulbecco’s Modified
Eagle’s medium (Lonza) supplemented with 10% fetal bovine
serum (Lonza), 1% L-glutamine (Lonza), 1% NEAA (only for
HEK-293FT) (Lonza), and 1% Penicillin/Streptavidine (P/S)
(GibcoH, Invitrogen). Etoposide and TSA (Sigma) were used at
a final concentration of 10 mM and 450 nM respectively,
KU55933 (Merk) at a final concentration of 1 mM. Stock solutions
of etoposide (10 mM), KU55933 (10,11 mM) were dissolved in
DMSO and TSA (3,3 mM) in water.
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Anti-ATM (ab78) used for western blots was from ABCAM,
anti-ATM (Ab-3, 819–844) used for ATM immunoprecipitation in
the kinase assay from Calbiochem, anti-HDAC1 (sc-7872), anti-
p65 (sc-109 or sc109x for supershift) and anti-p50 (sc-1191x) from
Santa Cruz, anti-HA (HA.11 mAb) from Covance. Antibody used
for ChIP assays were anti-histone H3 acetylated on Lys
9 (Millipore
07–352), anti-p65 (Santa Cruz sc-109x) and anti-HDAC1
(Diagenode pAb-053-050).
Plasmids and Site-directed Mutagenesis and
Recombinant Proteins
Plasmid expressing GST-ATM(1–247) was kindly provided by
Professor Khanna KK [45]. Fragments of human p65 cDNA with
the putative target Ser or Thr residue in its center were amplified
by PCR and cloned in the pGEX-5X-3 (GE Healthcare),
generating GST-p65(105–157), GSTp65(214–265), GSTp65(348–400),
GSTp65(397–456), GSTp65(521–551) fusion proteins. Duplex oligo-
nucleotides corresponding to a fragment of p53 were hybridized
and inserted in the pGEX-5X-3 to generate GSTp53(9–22). HA-
tagged human p65 was amplified by PCR from pCMV-HA p65
and cloned into pLenti6 Topo/D vector (Invitrogen). The reporter
plasmid kB-Luc was from Stratagene. All mutants were generated
by site-directed mutagenesis using the QuickChange Site-Directed
Mutagenesis Kit (Stratagene) and verified by sequencing. ATM wt
and kd purified recombinant proteins were kindly provided by
Professor Paull T (Howard Hughes Medical Institute, Austin,
Texas).
Stable Cell Line
Lentiviral stocks were obtained by collecting supernatant of
HEK-293FT cells, transiently co-transfected with the pLenti6 HA-
p65 wt, S547A, or S547D, each containing silent mutations
conferring resistance to an siRNA directed against endogenous
p65, with the psPAX2 (Plasmid 12260, Addgene) and with the
pVSV-G (a kind gift from Dr. T. Friedmann [46]). HEK-293 cells
were next infected with the lentiviral stock and treated with
Blasticidin (Invivogen) to select stably transduced HEK-293 cells
expressing siRNA resistant HA-p65.
Western Blotting and Electrophoretic Mobility Shift Assay
(EMSA)
Cytoplasmic and nuclear extracts were prepared as previously
described [47]. Cytoplasmic extracts were analyzed by Western
blotting as described [48]. Nuclear extract were obtained and
analyzed by EMSA as previously described [48] using
32P-labeled
oligonucleotide kB or IL8 probes. The kB probe (59-GGTTA-
CAAGGGACTTTCCGCTG-39; Eurogentec) corresponds to
HIV-1 long terminal repeat kB site and the IL8 probe (59-
GGTTATCGTGGAATTTCCTCTG-39; Eurogentec) corre-
sponds to the NF-kB site of the IL8 promoter. Supershift
experiments were performed as previously described [48].
ELISA
The concentration of IL8 released in the culture media of
treated and mock-treated cells was quantified using the Human
IL8 ELISA Ready-SET-Go!H kit (eBioscience) according to the
manufacturer’s recommendations.
Yeast Two Hybrid Assay
pGBKT7 expressing GAL4 binding domain fused to ATM
Heat repeat 1–2 (aa 1 to 150) was transformed into Saccharomyces
cerevisiae HA109 strain. HeLa cDNA library, fused to the GAL4
activation domain into the pGADT7, was provided into Saccha-
romyces cerevisiae Y187 strain (BD Yeastmaker
TM, BD Clontech).
After mating of the two yeast strains, co-transformants were plated
on media lacking tryptophan, leucine and histidine, and, four days
later, growing colonies at 30uC were screened with the X-Gal filter
assay. Colonies transferred onto a filter were disrupted in liquid
nitrogen and incubated with X-Gal 200 mL/mL in 30uC for
several hours. Colonies that turned blue within 24 hours were
scored as positive for interaction. The plasmids were purified from
these selected colonies and the genes amplified by PCR and
identified by sequencing.
GST Pull-down Assay
Bacterially expressed GST or GST-ATM(1–247) fusion protein
were purified on glutathione agarose beads. Twenty four hour
after transfection with pCMV-HA p65 wt, HEK-293 cells were
lysed in LB buffer (50 mM Tris HCl, 150 mM NaCl, 2 mM
EDTA, 1% NP-40, 10% glycerol, pH 8.00). One mg of protein
was pre-cleared with beads-linked GST for 1 hour at 4uC. The
pre-cleared lysate was next incubated with beads-linked GST-
ATM or beads-linked GST alone as negative control for 2 hours at
4uC. The beads were then washed three times with LB buffer and
the pulled down proteins were eluted with SDS loading buffer and
subjected to SDS-PAGE.
In vitro Kinase Assay
HEK-293 cells, were lysed in buffer (50 mM Tris HCl, 150 mM
NaCl, 10% glycerol (v/v), 1% Tween-20, 1 mM DTT, 0,5 mM
PMSF, 10 mM NaF, 50 mM b-glycerophosphate, 10 mM para-
Nitrophenyl phosphate, Complete
TM (Roche), pH 7,5). Aliquots
of 750 mg of protein were pre-cleared with protein A-agarose
(Pierce) for 1 h at 4uC. The pre-cleared lysates were next
incubated in the lysis buffer with 1 mg of ATM antibody
(Calbiochem) for 2 hours and for one additional hour with protein
A-agarose at 4uC. The beads were then washed twice with the lysis
buffer, once with LiCl buffer (100 mM Tris HCl, 0,5 M LiCl,
pH 7,5), and twice with kinase assay buffer (10 mM HEPES,
50 mM NaCl, 10 mM MgCl2 and 10 mM MnCl2, 1 mM DTT,
0,5 mM PMSF, 10 mM NaF, 50 mM b-glycerophosphate,
10 mM para-Nitrophenyl phosphate, Complete
TM, pH 7,5).
Immunoprecipitated proteins were resuspended in 50 ml of kinase
assay buffer, with or without ATM specific inhibitor KU55933
(1 mM), with 1 mlo f[ c-
32P]ATP (10mCi, 37.10
7 mBq/mMol,
Perkin Elmer) and with 1 mg of purified GST-p65 substrate. The
mix was incubated 30 min at 30uC. The reaction was stopped by
adding SDS loading buffer and was subjected to SDS-PAGE.
Proteins were transferred onto PVDF membrane and autoradio-
graphed.
Co-immunoprecipitation
Cells were washed with cold PBS, scraped and centrifuged.
Cells pellets were resuspended and incubated at 4uC for 30
minutes in IPLS buffer (20 mM Tris HCl, 120 mM NaCl,
0.5 mM EDTA, 0.5% NP40, 10% glycerol (v/v), 10 mM NaF,
50 mM b-glycerophosphate, Complete
TM, pH 7,5). Aliquots of
equal amount of proteins were pre-cleared with protein G-agarose
(Santa Cruz) for 1 h at 4uC.The pre-cleared lysates were next
incubated in the IPLS buffer with 1 mg of HA antibody (Covance)
overnight and for 2 additional hours with protein G-agarose at
4uC. The beads were then washed four times with IPLS buffer and
the immunoprecipitated proteins were eluted with SDS loading
buffer and subjected to SDS-PAGE.
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p65 siRNA (GCCCUAUCCCUUUACGUCA) [49], and
control siRNA (SilencerH Select Negative Control #2 siRNA) were
synthesized by Applied Biosystem and transfected into HEK-293
cells using ProFection Mammalian Transfection System –
Calcium Phosphate (Promega). Cells were harvested 72 hours
post-transfection. SiRNA efficiency was checked by western
blotting.
Luciferase Assay
Twenty four hours before treatment, HEK-293 cells were
transfected with JetPEI (Lucron Bioproduct) with corresponding
plasmid(s) (see Fig. 2) and two Luciferase reporter plasmids. The
first one is under the control of a kB-dependent promoter and the
second one (Renilla Luciferase) not. Eight hours after etoposide
treatment, cells were lysed and assayed for luciferase activity with
a Dual-Luciferase Reporter Assay System (Promega). The kB-
dependent Luciferase activity was normalized with the Renilla
Luciferase activity.
Quantitative Real Time Reverse Transcription-PCR (qRT
PCR)
Total RNA samples were extracted with RNeasy Mini Kit
(Qiagen) according to the manufacturer’s recommendations.
Reverse transcription and PCR were performed as previously
described [38]. The primers used to analyze the different
transcripts were designed with the software Primer Express
TM
(Applied Biosystems): ikba:F W( 5 9-CCAACCAGCCA-
GAAATTGCT-39) and RV (59-TCTCGGAGCTCAGGAT-
CACA-39); IL8,F W( 5 9-GAAGGAACCATCTCACTGTGTG-
TAA-39) and RV (59-ATCAG GAAGGCTGCCAAGAG-39);
SELE Fw (59-TGTGAGGAAGGCTTCATGTTGC-39) and Rv
(59-GCTGTGCACTGGAAAGCTTCA-39); V-CAM Fw (59-
TATGTCAATGTTGCCC CCAG-39) and Rv (59-
GATTTTCGGAGCAGGAAAGC-39); CXCL1 Fw
(59CCACTGCGC CCAAACC3’) and Rv (59TGCAGGATT-
GAGGCAAGCTT3’); A20 Fw (59-TCTCGGCTAT GACAGC-
CATCA-39) and Rv (59-TCAAATCTTCCCCGGTCTCTG-39);
CD83 Fw (59CCGCAGGTTCCCTACACGGT3’) and Rv
(59TGCTGTCCCCTGAGG TGGTCT3’); B2M Fw (59-GAG-
TATGCCTGCCGTGTG-39) and Rv (59- AATC-
CAAATGCGGCATCT –39) (Eurogentec).
Microarray
Total RNA samples were extracted with RNeasy Mini Kit
(Qiagen) according to the manufacturer’s recommendations. The
yield of the extracted RNA was determined by measuring the
optical density at 260 nm. The purity and quality of extracted
RNA were evaluated using the Experion RNA StdSens Analysis
kit (Bio-Rad Laboratories). High quality RNA with RNA Quality
Indicator (RQI) score greater than 8 was used for microarray
experiments. Gene expression profiling was performed using
Illumina’s multi-sample format Human HT-12 BeadChip that
contains more than 47000 probes and profiles twelve samples
simultaneously on a single chip (Illumina). For each sample,
250 ng total RNA was labeled using an Illumina TotalPrep 96-
RNA Amplification kit (Ambion) according to the manufacturer’s
instructions. Briefly, double stranded cDNA was synthesized using
T7-oligo (dT) primers and followed by an in vitro transcription
reaction to amplify RNA while biotin was incorporated into the
synthesized amplified RNA (aRNA) probe. The aRNA probe was
then purified and quantified using a NanoDrop spectrophotometer
(Thermo Fisher Scientific).
Biotinylated cRNA probe was hybridized to the Human HT-12
BeadChip Array (Illumina). Labeled aRNA (750 ng) was used for
hybridization to each array. The hybridization, washing, and
scanning were performed according to the manufacturer’s
instructions.
The arrays were scanned using a BeadArray Reader (Illumina).
The microarray images were registered and extracted automati-
cally during the scan according to the manufacturer’s default
settings. Raw microarray intensity data were analyzed with the
GenomeStudio software normalized using the quantile normali-
zation method according to the manufacturer’s recommendation.
Differential analyses have been performed with Genome Studio
software. The data have been normalized by quantile method and
the differential analyses have been performed using the Illumina
Custom model as differential expression algorithm. Significant
differentially expressed probes are filtered with Diff score up to 30
or below -30 for up-regulated or down-regulated compared to
reference, respectively. This threshold correspond to a p-value
,0.001 for differential test. The biological relevance of up- and
down-regulated genes were analyzed through the use of Ingenuity
Pathways Analysis (IngenuityH Systems, www.ingenuity.com).
Chromatin Immunoprecipitation Assay (ChIP assay)
Chromatin immunoprecipitation (ChIP) assays were carried out
as previously described [38]. The immunoprecipitated DNA was
analyzed by quantitative real time PCR with the SYBR Green
Master Mix in the ABI Sequence Detection System. The primers,
corresponding to the promoter region of IL8 gene, were designed
using the software Primer Express
TM: FW (59-GCCATCAGTTG-
CAAATCGTG-39) and RV (59-AGTGCTCCGGTGGCTTTT-
39) (Eurogentec).
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